UK Competition Body Steps Up Generic Hydrocortisone Probe
Executive Summary
Two generics firms have been provisionally found to have breached competition law by reaching agreements intended to delay the entry of competing products.
You may also be interested in...
Firms Vow To Appeal After CMA’s £260m Hydrocortisone Fines In UK
Firms censured by the UK’s CMA competition regulator over illegal deals that drove up the price of hydrocortisone for around a decade have vowed to appeal against the decision and the imposition of fines totaling more than £260m.
UK's Competition Watchdog Targets Four Firms Over Seven-Fold Prochlorperazine Price Hike
The UK CMA alleges that four companies were involved in a non-compete agreement that resulted in a 700% increase in the cost to the NHS of a generic medicine for nausea and dizziness.
UK Competition Watchdog Targets Four Firms Over Seven-Fold Prochlorperazine Price Hike
The UK CMA alleges that four companies were involved in a non-compete agreement that resulted in a 700% increase in the cost to the NHS of a generic medicine for nausea and dizziness.